Alector

Alector

Biotechnology Research

South San Francisco, California 17,014 followers

We are harnessing the immune system to treat neurodegeneration and cancer.

About us

We have always walked our own path, at Alector. That’s what led us to the bold thinking and fresh, new approach of empowering the body’s immune system to fight disease. Join us in our mission to eliminate neurodegeneration and cancer through immuno-neurology and immuno-oncology. We are developing a broad portfolio of programs, currently in various stages of clinical trials. Alector is based in South San Francisco, CA. We were founded in 2013 by thought leaders in biotechnology, neuroscience, and antibody drug discovery.

Website
http://alector.com
Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
South San Francisco, California
Type
Public Company
Founded
2013
Specialties
Biotechnology, Neurodegenerative disease, Neurodegeneration, and Immuno-neurology

Locations

  • Primary

    131 Oyster Point Blvd

    Suite 600

    South San Francisco, California 94080, US

    Get directions

Employees at Alector

Updates

Similar pages

Browse jobs

Funding

Alector 6 total rounds

Last Round

Post IPO equity

US$ 75.0M

See more info on crunchbase